1 – 7 of 7
- show: 100
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2023
-
Mark
Healthcare resource utilization and device-aided therapy discussions with eligible patients across the Parkinson's disease continuum : Revelations from the MANAGE-PD validation cohort
(
- Contribution to journal › Article
- 2022
-
Mark
Effects of Levodopa-Carbidopa Intestinal Gel on Dyskinesia and Non-Motor Symptoms Including Sleep : Results from a Meta-Analysis with 24-Month Follow-Up
(
- Contribution to journal › Scientific review
- 2021
-
Mark
Validation and clinical value of the MANAGE-PD tool : A clinician-reported tool to identify Parkinson's disease patients inadequately controlled on oral medications
(
- Contribution to journal › Article
- 2018
-
Mark
Systematic evaluation of levodopa-carbidopa intestinal gel patient-responder characteristics
(
- Contribution to journal › Article
- 2016
-
Mark
How can rAAV-α-synuclein and the fibril α-synuclein models advance our understanding of Parkinson's disease?
(
- Contribution to journal › Scientific review
- 2015
-
Mark
Levodopa-Carbidopa Intestinal Gel in Advanced Parkinson's Disease: Final 12-Month, Open-Label Results
(
- Contribution to journal › Article
- 2014
-
Mark
Continuous intrajejunal infusion of levodopa-carbidopa intestinal gel for patients with advanced Parkinson's disease: a randomised, controlled, double-blind, double-dummy study.
(
- Contribution to journal › Article